These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 404132)

  • 21. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma.
    Nisslein T; Freudenstein J
    Planta Med; 2007 Apr; 73(4):318-22. PubMed ID: 17354167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of estrogen biosynthesis and regression of mammary tumors by aromatase inhibitors.
    Brodie AM; Brodie HJ; Romanoff L; Williams JG; Williams KI; Wu JT
    Adv Exp Med Biol; 1981; 138():179-90. PubMed ID: 7342714
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.
    Spinola PG; Marchetti B; Mérand Y; Bélanger A; Labrie F
    Breast Cancer Res Treat; 1988 Dec; 12(3):287-96. PubMed ID: 3147727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of 4-hydroxy-4-androstene-3,17-dione on aromatase activity in granulosa cells from preovulatory follicles of rats, rabbits, and humans.
    Koos RD; LeMaire WJ; Hung TT; Brodie AM
    Steroids; 1985 Feb; 45(2):143-50. PubMed ID: 4089916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Nakamura J; Savinov A; Lu Q; Brodie A
    Endocrinology; 1996 Dec; 137(12):5589-96. PubMed ID: 8940388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.
    Dauvois S; Labrie F
    Breast Cancer Res Treat; 1989 Jan; 13(1):61-9. PubMed ID: 2495831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF; Hood WF
    Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.
    Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM
    J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M; Yano S; Hasegawa Y; Nakao K
    Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
    Brandt ME; Covey DF; Zimniski SJ
    J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase inhibitors prevent granulosa cell differentiation: an obligatory role for estrogens in luteinizing hormone receptor expression.
    Knecht M; Brodie AM; Catt KJ
    Endocrinology; 1985 Sep; 117(3):1156-61. PubMed ID: 2990868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
    De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
    Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase inhibitors: basic and clinical studies.
    Brodie AM; Coombes RC; Dowsett M
    J Steroid Biochem; 1987; 27(4-6):899-903. PubMed ID: 3320568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of implantation by aromatase inhibitors in ovariectomized mice.
    Wu JT
    J Reprod Fertil; 1984 Nov; 72(2):345-9. PubMed ID: 6512761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione as an inhibitor of aromatase.
    Furth PS; Rosenberger J; Marcotte PA; Robinson CH
    J Enzyme Inhib; 1990; 4(2):131-5. PubMed ID: 2098519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.